EBS · ISSUER CIK 1367644
Emergent BioSolutions Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Emergent BioSolutions Inc. insiders reported $0.00 of open-market purchases and $146K of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 2 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$146KInsider selling
−$146KNet open-market
Oct 7, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 202615:45 | Oct 7, 2026 | EBS | Director | S · Sell10b5-1 | $7.09 | −17,800 | 111,921 | -14% | −$126K | ||
| Oct 5, 202609:16 | Oct 1, 2026 | EBS | SVP, Products Business | S · Sell10b5-1 | $6.53 | −3,000 | 156,098 | -2% | −$20K |